Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
At a glance Composition: TB4 fragment Ac-LKKTETQ (1723) Claimed actions track TB4s actin/repair biology, but evidence is largely analytical/detection and preclinical, not approved clinical therapy
It was observed that BPC-157 appeared to be able to reverse the amphetamine-induced excitability in the murine models
BPC-157 + TB-500: Complementary Mechanisms Researchers studying both compounds note that their mechanisms are distinct but potentially complementary
The key active sequence (LKKTETQ) within TB-500 has been identified as the domain responsible for actin binding activity observed in in vitro assays
This peptide therapy physician guide covers both sides of that line
US$ 20.78
US$ 24.81
US$ 29.34
US$ 22.55
US$ 23.52
US$ 28.79
US$ 29.19
US$ 28.85
